191 related articles for article (PubMed ID: 21123822)
21. BDNF promotes the growth of human neurons through crosstalk with the Wnt/β-catenin signaling pathway via GSK-3β.
Yang JW; Ru J; Ma W; Gao Y; Liang Z; Liu J; Guo JH; Li LY
Neuropeptides; 2015 Dec; 54():35-46. PubMed ID: 26311646
[TBL] [Abstract][Full Text] [Related]
22. 6-Bromoindirubin-3'oxime (BIO) decreases proliferation and migration of canine melanoma cell lines.
Chon E; Flanagan B; de Sá Rodrigues LC; Piskun C; Stein TJ
Vet J; 2015 Aug; 205(2):305-12. PubMed ID: 25130776
[TBL] [Abstract][Full Text] [Related]
23. Transcriptomic profiling of the myeloma bone-lining niche reveals BMP signalling inhibition to improve bone disease.
Gooding S; Olechnowicz SWZ; Morris EV; Armitage AE; Arezes J; Frost J; Repapi E; Edwards JR; Ashley N; Waugh C; Gray N; Martinez-Hackert E; Lim PJ; Pasricha SR; Knowles H; Mead AJ; Ramasamy K; Drakesmith H; Edwards CM
Nat Commun; 2019 Oct; 10(1):4533. PubMed ID: 31586071
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of GSK-3β enhances neural differentiation in unrestricted somatic stem cells.
Dastjerdi FV; Zeynali B; Tafreshi AP; Shahraz A; Chavoshi MS; Najafabadi IK; Vardanjani MM; Atashi A; Soleimani M
Cell Biol Int; 2012 Nov; 36(11):967-72. PubMed ID: 22775567
[TBL] [Abstract][Full Text] [Related]
25. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells.
Bolzoni M; Donofrio G; Storti P; Guasco D; Toscani D; Lazzaretti M; Bonomini S; Agnelli L; Capocefalo A; Dalla Palma B; Neri A; Nicolini F; Lisignoli G; Russo F; Colla S; Aversa F; Giuliani N
Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592
[TBL] [Abstract][Full Text] [Related]
26. Maintained activity of glycogen synthase kinase-3beta despite of its phosphorylation at serine-9 in okadaic acid-induced neurodegenerative model.
Lim YW; Yoon SY; Choi JE; Kim SM; Lee HS; Choe H; Lee SC; Kim DH
Biochem Biophys Res Commun; 2010 Apr; 395(2):207-12. PubMed ID: 20362550
[TBL] [Abstract][Full Text] [Related]
27. Pharmaceutical inhibition of glycogen synthetase kinase 3 beta suppresses wear debris-induced osteolysis.
Geng D; Wu J; Shao H; Zhu S; Wang Y; Zhang W; Ping Z; Hu X; Zhu X; Xu Y; Yang H
Biomaterials; 2015 Nov; 69():12-21. PubMed ID: 26275858
[TBL] [Abstract][Full Text] [Related]
28. GSK3β negatively regulates oligodendrocyte differentiation and myelination in vivo.
Azim K; Butt AM
Glia; 2011 Apr; 59(4):540-53. PubMed ID: 21319221
[TBL] [Abstract][Full Text] [Related]
29. Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells.
Ghosh JC; Altieri DC
Clin Cancer Res; 2005 Jun; 11(12):4580-8. PubMed ID: 15958644
[TBL] [Abstract][Full Text] [Related]
30. Activation of Wnt/β-Catenin Signaling Pathway Enhances the Derivation of Buffalo (
Deng Y; Lao Y; Ruan Q; Zhang J; Luo C; Shi D; Lu F
Cell Reprogram; 2020 Aug; 22(4):217-225. PubMed ID: 32673062
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of p38alpha mitogen-activated protein kinase prevents the development of osteolytic bone disease, reduces tumor burden, and increases survival in murine models of multiple myeloma.
Vanderkerken K; Medicherla S; Coulton L; De Raeve H; Willems A; Lawson M; Van Camp B; Protter AA; Higgins LS; Menu E; Croucher PI
Cancer Res; 2007 May; 67(10):4572-7. PubMed ID: 17495322
[TBL] [Abstract][Full Text] [Related]
32. Glycogen synthase kinase-3beta (GSK-3beta) inhibitors AR-A014418 and B6B3O prevent human immunodeficiency virus-mediated neurotoxicity in primary human neurons.
Nguyen TB; Lucero GR; Chana G; Hult BJ; Tatro ET; Masliah E; Grant I; Achim CL; Everall IP;
J Neurovirol; 2009 Sep; 15(5-6):434-8. PubMed ID: 19688630
[TBL] [Abstract][Full Text] [Related]
33. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide screen reveals WNT11, a non-canonical WNT gene, as a direct target of ETS transcription factor ERG.
Mochmann LH; Bock J; Ortiz-Tánchez J; Schlee C; Bohne A; Neumann K; Hofmann WK; Thiel E; Baldus CD
Oncogene; 2011 Apr; 30(17):2044-56. PubMed ID: 21242973
[TBL] [Abstract][Full Text] [Related]
35. GSK3 inhibition prevents lethal GVHD in mice.
Klamer G; Shen S; Song E; Rice AM; Knight R; Lindeman R; O'Brien TA; Dolnikov A
Exp Hematol; 2013 Jan; 41(1):39-55.e10. PubMed ID: 22999867
[TBL] [Abstract][Full Text] [Related]
36. The polypeptide OP3-4 induced osteogenic differentiation of bone marrow mesenchymal stem cells via protein kinase B/glycogen synthase kinase 3β/β-catenin pathway and promoted mandibular defect bone regeneration.
Li C; Yang P; Kou Y; Zhang D; Li M
Arch Oral Biol; 2021 Oct; 130():105243. PubMed ID: 34416564
[TBL] [Abstract][Full Text] [Related]
37. [Effects of glycogen synthase kinase 3β overexpression in rat and glycogen synthase kinase 3β inhibitor SB-216763 on proliferation of hepatic oval cells].
Zhong JQ; Xie YK; Ji XK; Fu JH; Wang Y; Zhang QY; Shi HQ; Shan YF
Zhonghua Wai Ke Za Zhi; 2012 Nov; 50(11):1003-6. PubMed ID: 23302485
[TBL] [Abstract][Full Text] [Related]
38. Glycogen synthase kinase-3β indirectly facilitates interferon-γ-induced nuclear factor-κB activation and nitric oxide biosynthesis.
Kai JI; Huang WC; Tsai CC; Chang WT; Chen CL; Lin CF
J Cell Biochem; 2010 Dec; 111(6):1522-30. PubMed ID: 20872791
[TBL] [Abstract][Full Text] [Related]
39. Lithium chloride attenuates BMP-2 signaling and inhibits osteogenic differentiation through a novel WNT/GSK3- independent mechanism.
Li J; Khavandgar Z; Lin SH; Murshed M
Bone; 2011 Feb; 48(2):321-31. PubMed ID: 20932949
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
